Lung cancer screening uptake among high-risk individuals: a systematic review and meta-analysis
Abstract Background Low-dose computed tomography (LDCT) screening has been shown to reduce lung cancer mortality. However, uptake among high-risk individuals eligible for lung cancer screening remains low. The aim of this study was to determine the uptake and factors associated with lung cancer screening among high-risk individuals. Methods We systematically searched the Medline, Embase, and Scopus databases from inception to April 7, 2025. The protocol was registered with PROSPERO (CRD420251008323). Studies were eligible if they screened high-risk populations using LDCT and examined associated factors. Risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model was conducted to estimate the uptake and associated factors. Results Of 6,991 potentially relevant articles, 28 studies were included (total n = 2,312,274; range: 171-1,273,013 participants). The overall pooled uptake rate was 44% (95% CI: 24-66%), with significant heterogeneity observed. Studies showed that factors associated with non-uptake included older age, current smoking, racial minority status, lower level of education, lower income, presence of comorbidities, and lack of insurance. Meta-analyses revealed that current smokers were less likely to undergo screening compared to former smokers (OR 0.72, 95% CI: 0.59-0.87; p < 0.01), and non-white participants were less likely to undergo screening compared to white participants (OR 0.72, 95% CI: 0.56-0.92; p < 0.01). For risk of bias, only six studies were rated as having ‘moderate risk,’ while the rest were rated as having low risk. Conclusions Lung cancer screening uptake remains moderate among high-risk individuals. Targeted interventions should prioritize current smokers and individuals from non-white minority groups. Lung cancer screening campaigns should be expanded more widely, especially among current smokers and minority populations, to reduce disparities in lung cancer screening. Key messages • Lung cancer screening uptake remains moderate among high-risk individuals, particularly current smokers and those of non-white minority status. • Targeted interventions should focus on current smokers and minority populations to reduce disparities in lung cancer screening.
Authors
- Geva Greenfield (ORCID: https://orcid.org/0000-0001-9779-2486)
- Azeem Majeed (ORCID: https://orcid.org/0000-0002-2357-9858)
- Wiriya Mahikul (ORCID: https://orcid.org/0000-0001-5834-5173)
- Jennifer Kathleen Quint (ORCID: https://orcid.org/0000-0003-0149-4869)
- Benedict Hayhoe (ORCID: https://orcid.org/0000-0002-2645-6191)
- Ying Huang (ORCID: https://orcid.org/0000-0003-2288-8314)
Institutions
- Chulabhorn Hospital (TH)
- Imperial College London (GB)
Publication Details
- Journal
- European Journal of Public Health
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1093/eurpub/ckaf161.1018
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00